netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Results

Looking for Aflibercept found 8 matches

Open monograph to display formulary status BNF Category
  Aflibercept  (Eylea) Eye - Subfoveal choroidal neovascularisation - 11.08.02
  Cytotoxic Drug Aflibercept  (Zaltrap) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy  (08.01.05)
link in drug section NICE TA409:Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (Sep 2016) (11.08.02)
link in drug section NICE TA486:Aflibercept for treating choroidal neovascularisation (Nov 2017) (11.08.02)
link in drug section Use as per NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (July 2013) (11.08.02)
link in drug section Use as per NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion(February 2014) (11.08.02)
link in drug section Use as per NICE TA346: Aflibercept for treating diabetic macular oedema (July 2015) (11.08.02)


 

netFormulary